These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28754609)

  • 21. From innovative polymers to advanced nanomedicine: key challenges, recent progress and future perspectives: the second Symposium on Innovative Polymers for Controlled Delivery Suzhou, China, 11–14 September 2012 .
    Feijen J; Hennink WE; Zhong Z
    Nanomedicine (Lond); 2013 Feb; 8(2):177-80. PubMed ID: 23394154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Theranostic nanomedicine.
    Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
    Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanomedicine to Deal With Cancer Cell Biology in Multi-Drug Resistance.
    Tekchandani P; Kurmi BD; Paliwal SR
    Mini Rev Med Chem; 2017; 17(18):1793-1810. PubMed ID: 26891930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanoscale Delivery Systems: Actual and Potential Applications in the Natural Products Industry.
    Simona AD; Florina A; Rodica CA; Evelyne O; Maria-Corina S
    Curr Pharm Des; 2017; 23(17):2414-2421. PubMed ID: 28228070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The progress of nanomedicine inspired by bacteriophage].
    Fan XY; Chen J; Xie JP
    Yao Xue Xue Bao; 2012 Jan; 47(1):29-33. PubMed ID: 22493801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Not just for tumor targeting: unmet medical needs and opportunities for nanomedicine.
    Lepeltier EA; Nuhn L; Lehr CM; Zentel R
    Nanomedicine (Lond); 2015; 10(20):3147-66. PubMed ID: 26447353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanomedicines Targeting the Tumor Microenvironment.
    Tong R; Langer R
    Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancing the Efficacy of Active Pharmaceutical Ingredients in Medicinal Plants through Nanoformulations: A Promising Field.
    Chen Y; Tang Y; Li Y; Rui Y; Zhang P
    Nanomaterials (Basel); 2024 Oct; 14(19):. PubMed ID: 39404324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Nanomedicine Structure-Activity Framework for Research, Development, and Regulation of Future Cancer Therapies.
    Youden B; Jiang R; Carrier AJ; Servos MR; Zhang X
    ACS Nano; 2022 Nov; 16(11):17497-17551. PubMed ID: 36322785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
    Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
    Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanotechnology applications in medicine and dentistry.
    Gupta J
    J Investig Clin Dent; 2011 May; 2(2):81-8. PubMed ID: 25426600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug delivery of the future: Chasing the invisible gorilla.
    Park K
    J Control Release; 2016 Oct; 240():2-8. PubMed ID: 26519857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanomedicine for Drug Delivery throughout the Alimentary Canal.
    Cote B; Rao D; Alani AWG
    Mol Pharm; 2022 Aug; 19(8):2690-2711. PubMed ID: 33605146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs.
    Parveen S; Sahoo SK
    Clin Pharmacokinet; 2006; 45(10):965-88. PubMed ID: 16984211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy.
    Shen S; Liu M; Li T; Lin S; Mo R
    Biomater Sci; 2017 Jul; 5(8):1367-1381. PubMed ID: 28664207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
    Danhier F
    J Control Release; 2016 Dec; 244(Pt A):108-121. PubMed ID: 27871992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ; Mousa SA
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanotechnology for the delivery of phytochemicals in cancer therapy.
    Xie J; Yang Z; Zhou C; Zhu J; Lee RJ; Teng L
    Biotechnol Adv; 2016; 34(4):343-353. PubMed ID: 27071534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Careers in nanomedicine and drug delivery.
    Nance E
    Adv Drug Deliv Rev; 2019 Apr; 144():180-189. PubMed ID: 31260712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid-enveloped hybrid nanoparticles for drug delivery.
    Tan S; Li X; Guo Y; Zhang Z
    Nanoscale; 2013 Feb; 5(3):860-72. PubMed ID: 23292080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.